The clinical trial will assess the safety and effectiveness of a pulmonary vein isolation-only strategy to treat patients with persistent atrial fibrillation using the company’s Arctic Front Advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback